Considering the methodological limitations and external validity issues of pharmacological drug trials in adult ADHD: An umbrella review (Open Protocol)

Kim Boesen; Asger Sand Paludan‐Müller; John P A Ioannidis

doi:10.1101/2021.12.07.21267067

Related publications

Article2025

Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making

Corentin J. Gosling, Miguel Garcia‐Argibay, Michele De Prisco, Gonzalo Arrondo, Anaël Ayrolles, S. Antoun, Serge Caparos, Ana Catalán, Pierre Ellul, Maja Dobrosavljevic, Luís C. Farhat, Giovanna Fico, Luis Eudave, Annabeth P. Groenman, Mikkel Højlund, Lucie Jurek, Mikaïl Nourredine, Vincenzo Oliva, Valeria Parlatini, Constantina Psyllou, Gonzalo Salazar de Pablo, Anneka Tomlinson, Samuel J. Westwood, Andrea Cipriani, Christoph U Correll, Dong Keon Yon, Henrik Larsson, Edoardo G. Ostinelli, Jae Il Shin, Paolo Fusar‐Poli, John P A Ioannidis, Joaquim Raduà, Marco Solmi, Richard Delorme, Samuele Cortese

Article2022

The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials

Kyuyeon Cho, Seoyeon Park, Ai Koyanagi, Louis Jacob, Dong Keon Yon, Seung Won Lee, Min Seo Kim, Seung Up Kim, Beom Kyung Kim, Jae Il Shin, Lee Smith

Preprint2022

Mapping and systematic appraisal of umbrella reviews in biomedical literature: A protocol

Lazaros Belbasis, Robin D Brooker, Emmanuel A. Zavalis, Angelo Maria Pezzullo, Cathrine Axfors, John P A Ioannidis

Article2025

Comparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations

Behnood Bikdeli, Joseph S. Ross, Syed Bukhari, Molly M. Jeffery, Professor Gregory Lip, Seng Chan You, David J. Cohen, James L. Januzzi, Joshua D. Wallach

Preprint2020

FDA and EMA clinical research guidelines: Assessment of trial design recommendations for pivotal psychiatric drug trials (Protocol)

Kim Boesen, Peter C Gøtzsche, John P A Ioannidis

Considering the methodological limitations and external validity issues of pharmacological drug trials in adult ADHD: An umbrella review (Open Protocol)

Abstract

Discussion(0)

Open reviews(0)